SAN FRANCISCO– A large retrospective study identified risk factors for anastomotic leak within 30 days of colectomy.
The analysis of data on 13,684 patients looked at a multicenter cohort, compared...
SILVER SPRING, MD. – The majority of a Food and Drug Administration advisory panel agreed that the risk-benefit profile of panobinostat as add-on treatment to bortezomib and dexamethasone did not...
BOSTON – When a palliative care oncologist partners with a medical oncologist on everyday rounds and in everyday practice on an inpatient floor, both patients and the clinicians who provide their...
Colorectal cancer rates have declined in both men and women since 1975, particularly in those over age 75 years, but there has also been a significant increase in the incidence among those aged 20-34...
Close to 8 million women aged 21-65 years were not screened for cervical cancer in the past 5 years even though the disease claims nearly 4,000 lives per year, according to 2012 data, the Centers for...
BOSTON – The risk for cognitive decline following cancer treatment varies by both cancer and therapy types, and can range from subtle changes to severe deficits, according to a researcher.
Patients...
Fecal immunochemical testing with a low hemoglobin threshold for colonoscopy resembled one-time, primary colonoscopy for detecting advanced neoplasias in the first-degree relatives of colorectal...
Patients with inflammatory bowel disease who took thiopurines for at least a year had an almost sixfold greater rate of lymphoma than did the general population, researchers reported in the November...
The risk of recurrence (ROR) score provides clinically meaningful prognostic information after postmenopausal women with early-stage breast cancer complete 5 years of tamoxifen therapy, according to...
CORONADO, CALIF.– Today’s clinicians are ordering more postdiagnosis imaging tests in patients with thyroid cancer than they did in the early 1990s, results from the largest study of its kind...
